The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes by baseline tumor burden using the 6-and-12 score in EMERALD-1: A phase 3 study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolization (TACE) in embolization-eligible unresectable hepatocellular carcinoma (uHCC).
 
Joseph Erinjeri
Consulting or Advisory Role - AstraZeneca
 
Muhammad Beg
No Relationships to Disclose
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Bayer; Roche; SIRTEX Medical
Research Funding - AstraZeneca (Inst); Bayer Schering Pharma (Inst); BMS GmbH & Co. KG (Inst); Incyte (Inst); Merck (Inst); MSD (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Roche
 
Zhenggang Ren
Consulting or Advisory Role - MSD; Roche
 
Bruno Sangro
Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Eisai; Incyte; Roche/Genentech; Sanofi Pasteur; Sirtex Medical
Speakers' Bureau - AstraZeneca; Eisai; Incyte; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Roche; Sirtex Medical
 
Stephen Chan
Honoraria - AstraZeneca; Eisai; Elevar Therapeutics; Ipsen; MSD (Inst); Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Elevar Therapeutics; Exelixis; MSD Oncology; Roche
Research Funding - Eisai; MSD
Travel, Accommodations, Expenses - Ipsen; Roche
 
Valeriy Breder
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Roche
Travel, Accommodations, Expenses - Bayer; Roche
 
Chang-Fang Chiu
No Relationships to Disclose
 
Thomas Decaens
Honoraria - AstraZeneca, BMS, Roche, Abbvie, Gilead
Consulting or Advisory Role - AstraZeneca, BMS, Roche, Abbvie, Gilead
Research Funding - Transgene
Travel, Accommodations, Expenses - AstraZeneca, BMS, Roche, Abbvie, Gilead
 
Jeong Heo
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca/MedImmune; Medvir; Surrozen
Speakers' Bureau - Abbvie; AstraZeneca/MedImmune; Gilead Sciences; Gilead Sciences; Oncolys BioPharma; Roche; Yuhan
Research Funding - Gilead Sciences; Roche
 
Rebecca Griffin
Employment - AstraZeneca
 
Sajid Ali
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kavitha Balaji
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai; Roche
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); Eisai (Inst); GE Healthcare (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)